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Leukotrienes (LTs), formed by the 5-lipoxygenase-(5-LO-) catalyzed oxidation of arachidonic acid, are lipid mediators that
have potent proinﬂammatory activities. Pharmacologic or genetic inhibition of 5-LO biosynthesis in animals is associated with
increased mortality and impaired clearance of bacteria, fungi, and parasites. LTs play a role in the control of helminth and
protozoan infections by modulating the immune system and/or through direct cytotoxicity to parasites; however, LTs may also be
associated with pathogenesis, such as in cerebral malaria and schistosomal granuloma. Interestingly, some proteins from the saliva
of insect vectors that transmit protozoans and secreted protein from helminth could bind LTs and may consequently modulate
the course of infection or pathogenesis. In addition, the decreased production of LTs in immunocompromised individuals might
modulate the pathophysiology of helminth and protozoan infections. Herein, in this paper, we showed the immunomodulatory
and pathogenic roles of LTs during the helminth and protozoan infections.
1.Introduction
Leukotrienes (LTs), ﬁrst described by Samuelsson’s group
[1, 2], are a class of lipid mediators involved in several
diseases but classically known for their eﬀects on asthma and
allergy. The generation of leukotrienes (LTs) is dependent
upon the action of 5-lipoxygenase (5-LO) in association
with membrane-bound 5-lipoxygenase-activating protein
(FLAP) on arachidonic acid (AA). AA is derived through the
actionofcytosolicphospholipaseA2 (cPLA2)and/orsecreted
phospholipase A2 (sPLA2) on membrane phospholipids [3].
LTA4, an unstable precursor of all leukotrienes, is quickly
metabolized to one of the two diﬀerent classes of LTs,
LTB4 (by LTA4 hydrolase) or LTC4 (by LTC4 synthase) and
its metabolites (LTD4 and LTE4)[ 4]. Collectively, LTC4,
LTD4,a n dL T E 4 were previously known as the slow-reacting
substance of anaphylaxis (SR-A) and are currently termed
the cysteinyl LTs (cysLTs) [3, 4]. The receptors for LTB4
(BTL1 and BTL2) and cysteinyl LTs (CysLT1 and CysLT2)
arecellsurfaceGprotein-coupledreceptors[3].Additionally,
some studies support the existence of other CysLT receptors
[5, 6]. Some cells express both BTLs and cysLTs; however,
the expression of these receptors diﬀers in diﬀerent cells
types. In addition, these receptors are also expressed on
peripheral blood leukocytes [7, 8]. LT receptors and 5-LO
are expressed mainly in immune cells [6], and LTs play
important roles in innate and adaptive immune responses
and are involved in several inﬂammatory and infectious
diseases [4, 9]. For example, cysLTs increase vascular perme-
ability and edema, and LTB4 is involved in leukocyte chemo-
taxis, lysosomal enzyme secretion, neutrophil degranulation,
adhesion molecule expression, defensins and nitric oxide
(NO) production, phagocytosis, and other functions [9].
LTs are produced during the interaction of phagocytes and
microorganisms in vitro and experimental infections in vivo
[9]. Pharmacologic or genetic approaches to reduce or block
the LT biosynthesis pathways decrease the phagocytic and
antimicrobial activities against bacteria [10], fungi [11], and
parasites [12, 13]. In addition, immunodeﬁcient individuals,
such as HIV patients, are characterized by low LT production
[14], which has been associated with impaired immune
responses and infection control. LTs play important roles in
both Th1 and Th2 immune responses, which are involved
in the defense against protozoan and helminth infections,2 Mediators of Inﬂammation
respectively. In light of the current research on the role of
LTs in infectious diseases, we have divided the current review
intotwosectionsfocusingon(1)protozoaninfectionand(2)
helminth infection.
2. Leukotrienes andProtozoanInfection
Each year, protozoan parasites infect many people world-
wide, mainly in developing countries, causing serious health,
political, social, and economic problems. The major proto-
zoan parasites with clinical importance for human diseases
are Plasmodium ssp, Leishmania ssp, Trypanosoma cruzi,
Toxoplasma gondii, Trichomonas vaginalis, and Entamoeba
histolytica [15–17]. The ﬁrst three of these organisms are
obligate intracellular protozoan parasites that are trans-
mitted to vertebrate hosts by insect vectors. T. gondii is
also an obligate intracellular protozoan parasite; however,
its transmission to human hosts occurs by ingestion of
raw or undercooked meat containing tissue cysts or food
or water contaminated with oocysts. T. vaginalis and E.
histolytica are extracellular protozoan parasites. T. vaginalis
is transmitted sexually (trophozoites) and E. histolytica is
transmitted through food and water contaminated with
cysts [15–17]. Protective immunity against protozoans is
mediated mainly by T helper 1 (Th1) responses which are
characterized by the production of inﬂammatory cytokines,
such as IL-12, which is required for the development of
the Th1 immune response, and interferon gamma (IFN-γ)
and tumor necrosis factor alpha (TNF-α), which activate
macrophagestoproduceNO,whichisinvolvedinthecontrol
of parasite replication [16, 18–20].
Reiner and Malemud [21, 22] conducted the ﬁrst stud-
ies to demonstrate the role of leukotrienes in protozoan
infection (Leishmania spp). Research in this area has in-
creased in recent decades. The main eﬀects of LTs, in both
innate and adaptative immune responses, during the pro-
tozoan infections are illustrated in Figure 1. Mouse strains
resistant (C57BL/6) to Leishmania infection mount Th1
immune responses against Leishmania. In contrast, infection
of susceptible mouse strain (BALB/c) is associated with the
development of a Th2 immune response. In vitro stud-
ies have demonstrated increased LTC4 production in spleno-
cytes and macrophages from L. donovani-infected or unin-
fected BALB/c mice upon stimulation with nonspeciﬁc
(phytohemagglutinin) or speciﬁc (L. donovani amastigotes)
stimuli [21, 22]. In another study, splenocytes from BALB/c
mice stimulated with antigens from L. major promastigotes
displayedincreasedLTB4 andIL-4productionwithconcomi-
tantdecreasesinIFN-γ andTNF-αproduction[23].Serezani
et al. [24] demonstrated an increase in the parasite burden
of BALB/c macrophages infected with L. amazonensis when
compared to macrophages from the resistant mouse strain
C3H/HePas. This eﬀect was associated with lower levels of
LTB4 in macrophages from BALB/c mice. In agreement with
thisﬁnding,macrophagesfromeithersusceptibleorresistant
mice treated with MK0591 (FLAP inhibitor) and U75302
(BLT1 antagonist), but with not MK571 (cysLT1 antagonist),
as well as macrophages derived from 5-LO-deﬁcient mice,
exhibited decreased leishmanicidal activity. Interestingly,
treatment with exogenous LTB4 or LTD4 favored parasite
killing by macrophages from BALB/c mice. Supporting these
in vitro results, susceptible and resistant mice treated with
zileuton (inhibitor of 5-LO) or 5-LO-deﬁcient mice infected
with L. amazonensis displayed larger footpad lesions than
nontreated or wild type animals [24].
The success of Lutzomyia longipalpis, an insect vector of
the Leishmania ssp, at blood feeding on mammals depends
on the inhibition of the immediate inﬂammatory response
(e.g., increased vascular permeability, swelling, pain, and
itching). It is well known that active substances in the
saliva of hematophagous arthropods facilitate the uptake of
blood by counteracting host hemostatic, inﬂammatory and
immunological defenses [25–28]. Mixed lysates from the
salivary glands of L. longipalpis signiﬁcantly increased the
cutaneous lesions and/or parasite loads in the footpads of
mice infected with L. major or L. braziliensis when compared
to infected animals not exposed to the saliva lysates [29, 30].
In addition, the modulation of infection by saliva was IL-4-
dependent [29]. In agreement with these results, the salivary
gland extract of L. longipalpis exhibited anti-inﬂammatory
activities by decreasing TNF-α and LTB4 production, neu-
trophil numbers, and LTB4-induced chemotactic activity
in a murine ovalbumin-induced peritonitis model [31].
In addition, IL-10 and IL-4 production was increased in
this model. Taken together, these ﬁndings suggest that LTs,
and particularly LTB4, play a role in immune response to
Leishmania infection by promoting leishmanicidal activity
and consequently, control of infection. Therefore, the mod-
ulation of LTB4 during infection in association with the
modulation of the immune system during Leishmania trans-
mission (by saliva from the insect vector) in synergism with
genetic factors (susceptibility; Th2) could markedly aﬀect
Leishmania infection in humans.
Thecomponentsderivedfromthesalivaofthearthropod
vector of malaria (e.g., Anopheles stephensi) have also phar-
macologic eﬀects, such as inhibition of inﬂammation and
coagulation [32], similar to those observed in the saliva of
insect vectors of Leishmania. In addition, these proteins also
have the ability to neutralize inﬂammatory small molecules
by rapid binding. The AnSt-D7L1 protein produced by A.
stephensi binds cysLTs (LTC4,L T D 4,a n dL T E 4)b u td o e s
notchemicallymodifythem.AnSt-D7L1eﬀectivelyinhibited
LTC4-induced ileal contraction by binding LTC4, thereby
preventing interactions between this molecule and its appro-
priate cellular receptor [25]. The eﬀects of LTC4 inhibition
on the course of malaria infection as well as the inﬂuence in
the malaria pathogenesis are not known.
In the experimental cerebral malaria model, mice infect-
ed with Plasmodium berghei showed increased LTB4 pro-
duction in the serum. Interestingly, treatment with aspirin,
which may direct arachidonic acid metabolism away from
the cyclooxygenase (COX) pathway and toward the LO
pathway [33], induced increased parasitemia and death of
infected mice. This eﬀect was associated with the overpro-
duction of LTB4 in the serum [34]. In agreement with these
results, children with cerebral malaria treated with salicylate
demonstrated complications of severe malaria (metabolicMediators of Inﬂammation 3
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Figure 1: Modulation of innate and adaptive immune responses by LTs during the protozoan infections. Protective immunity against
protozoans is mainly mediated by Th1 responses characterized by the production of inﬂammatory cytokines, such as IFN-γ, which activate
macrophages to control of parasite replication. Macrophages are a source of LTs. (A) LTB4 induces cytotoxicity in parasites. (B) LTB4 and
LTD4 favored parasite killing by macrophages. (C) LTB4 induces chemotaxis of CD4+ Tc e l l s .( D )L T B 4 induces the production of Th1
cytokines, such as IFN-γ.
acidosis, hypoglycemia, and death) [35]. Although IFN-γ
plays a protective role in malaria infection, it has also been
associated with the immunopathology of cerebral malaria
[36, 37]. Besides playing a role in initiating the Th1 immune
response mediated by dendritic cells [38], LTB4 is also an
inducer of Th1 cytokines, such as IFN-γ [39]. Therefore, the
overproduction of LTB4 after aspirin treatment in experi-
mental and human cerebral malaria could be associated with
the overproduction of IFN-γ. Further studies are needed to
evaluate this hypothesis.
Eryptosis, or suicidal death of erythrocytes, which occurs
in a wide variety of diseases including malaria [40], is char-
acterized by cell shrinkage, membrane blebbing, and expo-
sure of phosphatidylserine (PS) at the cell surface [41].
Like apoptotic cells, PS-exposing erythrocytes are identiﬁed
by macrophages and are engulfed, degraded, and removed
from the circulation [42]. Ayi et al. [43] demonstrated in-
creased phagocytosis of mutant red blood cells infected with
trophozoites of P. falciparum, which may represent a pro-
tective mechanism against infection. Remarkably, an in vitro
assay demonstrated that erythrocytes were able to produce
cysLTs upon energy depletion [44]. In addition, exogenous
treatment with LTC4,b u tn o tL T B 4, stimulated eryptosis.
These eﬀects were inhibited by cysLT1 receptor antagonists
and by the 5-LO inhibitor (BW B70C) [44]. These results
suggest that LTC4 might confer protection during the course
of malaria by accelerating the clearance of infected erythro-
cytes. On the other hand, excessive eryptosis might favor the
development of anemia; thus, LTC4 might have a dual eﬀect
in malaria pathogenesis.
During T. gondii infection, an eﬃcient immune response
is important to contain dissemination of the parasite and
to prevent mortality of the host. LTC4,L T D 4,a n df r e e
AA were detected when murine macrophages from Swiss
mice were cultured with viable T. gondii [45]. In contrast,
when macrophages from resistant mice (BALB/c; major
histocompatibility complex haplotypes H2d)[ 46]o rh u m a n
macrophages [47] were cultured with viable T. gondii,n o5 -
LO products were observed. Accordingly, prior incubation
of human macrophages with viable T. gondii decreased the
LTB4 release induced by the calcium ionophore A23187,
suggesting that T. gondii inhibits LTB4 production. This
eﬀect was restored by IFN-γ treatment [47]. In addition,
treatment with zileuton (an inhibitor of 5-LO) decreased the
toxoplasmacidal activity of IFN-γ in human macrophages,
whereas exogenous LTB4 promoted intracellular killing of
ingested T. gondii in human monocytes [47]. This eﬀect
might be associated with the eﬀect of LTB4 on the induction
of cytotoxicity (surface membrane vesiculation, extrava-
sation of cytoplasmic contents into a space between the
intermembrane spaces and cytoplasmic vacuolization) in
T. gondii tachyzoites [47, 48]. In agreement with these
results, 5-LO-deﬁcient mice infected with T. gondii displayed
decreased survival as a consequence of an excessive inﬂam-
matory response characterized by elevated IL-12 and IFN-γ
concentrations in the serum and CD4+ and CD8+ T-cell
inﬁltration in the brain tissue and not of increased parasitic
burden [49]. The increased inﬂammation in the absent of
LTs might indicate a compensatory mechanism to control
the parasite infection. Taken together, these ﬁndings suggest4 Mediators of Inﬂammation
that the downregulation of LTs production, and particularly
of LTB4,b yT. gondii might be considered an evasion mech-
anism, as this lipid mediator can promote cytotoxicity and
toxoplasmacidal activity. Thus, LTB4 plays an important role
in toxoplasmosis.
Studies by our group and others have demonstrated re-
duced LT synthesis (e.g., LTB4) in HIV-infected subjects [14,
50].AlthoughtheclinicalmanifestationofT. gondii infection
is usually asymptomatic in immunocompetent individuals,
immunocompromised individuals, such as HIV-seroposi-
tivepatients,exhibitreactivationoflatenttissuecysts(brady-
zoites become tachyzoites) and consequent toxoplasmic en-
cephalitis or retinochoroiditis [51, 52]. Interestingly, in
agreement with these results, the LTB4 and LTC4 concen-
trations in the cerebrospinal ﬂuid of HIV-1-seropositive pa-
tients with toxoplasmic encephalitis but not those of HIV-
1-seropositive patients without inﬂammatory disease or
encephalitis were below the detection limit [53]. These re-
sults support those described above and suggest that the
reduced basal production of LTs in HIV-1-seropositive
patients synergizes with the suppression of LTs by T. gondii.
Moreover, this synergistic decrease in LT production might
contribute to the pathogenesis of cerebral toxoplasmosis
through the increased reactivation of bradyzoites from tissue
cysts and the reduced control of the parasitic infection.
Protective immunity against toxoplasmosis and Chagas
disease is mediated by Th1 cells, CD8+ T cells, and IFN-γ
[16]. Chagas’ heart disease is a severe clinical manifestation
of Trypanosoma cruzi infection [54]. In chronic Chagas dis-
ease, cardiomyopathy is observed as an inﬂammatory pro-
cess characterized by the inﬁltration of T cells and macro-
phages, resulting in myocarditis, ﬁbrosis, and heart ﬁber
damage[54].TreatmentwithLTinhibitorshasdemonstrated
beneﬁcial eﬀects in cardiovascular pathologies [55, 56].
T lymphocytes from patients with chronic Chagas’ heart
disease [57] or from chagasic mice [58] show increased con-
tractile activity (positive inotropic and chronotropic eﬀects)
of heart (atrial) in an in vitro assay. Interestingly, pre-
treatment with lipoxygenase inhibitors (NDGA) or a cysLT
receptor antagonist (FPL 55712) decreased this eﬀect. In a
separate study, LTC4 production was observed in the super-
natants of murine atria cocultured with T lymphocytes from
chagasic mice [58]. In accordance with these results, LTB4
induces chemotaxis of lymphocytes (CD4+/CD8+ T cells)
[8, 59]. Therefore, LTs might modulate the cardiac pathology
of Chagas disease by modulating the immune response pro-
ﬁle during this infection.
LTB4 [60]a n dL T C 4 [61] also increased the phagocytic
and trypanocidal activity of murine macrophages incubated
with T. cruzi trypomastigotes in vitro. In addition, LTB4 re-
stored NO and TNF-α levels, which were decreased by an
LTB4 receptor antagonist (CP-105,696) [62]. CP-105,696
treatment also decreased the trypanocidal activity of IFN-γ
in murine macrophages. With the use of pharmacologic
(LTB4 receptor antagonist and LO inhibitors) and genetic
approaches (5-LO-deﬁcient mice), researchers have demon-
strated increased parasitemia in mice infected with T. cruzi
[63–65]. In addition, the following anti-inﬂammatory pro-
ﬁles were observed in T. cruzi infection: (1) decreased leuko-
cyte inﬁltration in the heart; (2) reduced numbers of CD4+,
CD8+,a n dI F N - γ-producing cells in the heart; (3) decreased
ﬁbrosis in cardiac tissues; (4) decreased iNOS expression
and NO production in the heart; (5) decreased TNF-α
and IFN-γ in the heart; (6) increased IL-10 in the heart;
and (7) decreased oxidative stress in erythrocytes [63–65].
The survival of 5-LO-deﬁcient mice was greatest when the
animals were infected with low number of parasites [64]
when compared to animals infected with higher number of
parasites[65].Takentogether,theseﬁndingssuggestthatLTs,
and speciﬁcally LTB4, play important roles in the control of
Chagas disease.
Trichomoniasis is the most common sexually transmit-
ted disease. The supernatant of viable T. vaginalis induced
increased LTB4 production in neutrophils in an IgG-
and complement-(C5-) dependent manner. This eﬀect was
decreased by SC-41930 (LTB4 antagonist) treatment [66]. In
the vaginal discharges from patients with vaginal trichomo-
niasis, Shaio and Lin [67] demonstrated a positive correla-
tion between neutrophils and LTB4 production in symp-
tomatic patients when compared to asymptomatic patients.
These results suggest that LTB4 is involved in the inﬂam-
mation and symptoms of trichomoniasis. The most relevant
eﬀects of LTB4 in protozoan infections are illustrated in
Figure 2.
Entamoebiasis causes high morbidity and mortality in
the developing world. Peritoneal and splenic macrophages
from na¨ ıve mice incubated directly with E. histolytica tro-
phozoites or with their excretory/secretory products show
increased LTC4 production. On the other hand, peritoneal
and splenic macrophages from E. histolytica-infected mice
produced low levels of LTC4. Interestingly, amoebic liver
abscess-derived macrophages were unable to produce LTC4
[68]. The downregulation of LTC4 by E. histolytica in inﬂam-
matory but not na¨ ıve macrophages might be associated with
the pathogen’s evasion mechanisms.
3. Leukotrienes andHelminthic Infections
Over one-third of the human population is infected with
one or more species of helminths [69, 70]. Although host
immune responses attempt to control or expel the parasites,
these organisms can develop evasion strategies to modulate
the innate and adaptive immune responses, allowing them to
survive. The most prevalent human helminthiases are caused
by nematodes (e.g., Ascaris lumbricoides, Strongyloides spp.,
Enterobius vermicularis, and Trichuris trichiura), including
ﬁlarial worms (e.g., Brugia malayi and Wuchereriabancrofti),
hookworms (e.g., Ancylostoma duodenale and Necator amer-
icanus), and trematodes (Schistosoma spp).
Asthma and helminthiasis present similar features and
are both controlled by a CD4+ T-cell immune response.
Initial exposure of the immune system to allergic or parasitic
antigens leads to the activation of a subset of T cells known
as Th2 cells, which orchestrate the immune response to these
exogenous antigens by secreting cytokines, including IL-4,
IL-5, and IL-13 [71–74]. In addition, the accumulation of
eosinophils in the blood (eosinophilia), as well as in diﬀerentMediators of Inﬂammation 5
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Figure 2: Roles of LTB4 on protozoan infections. LTB4 is involved in the control of leishmaniasis, toxoplasmosis, and trypanosomiasis.
LTB4 is also involved in the inﬂammation and symptoms of trichomoniasis. The overproduction of LTB4, after aspirin treatment, could be
associated with the exacerbated pathogenesis of cerebral malaria.
organs and tissues [75], is a hallmark of both diseases. Eos-
inophils are multifunctional cells that are involved in tissue
damage as a consequence of the release of cationic proteins
[76–79]. In addition, eosinophils are important sources of
variousinﬂammatoryandregulatorycytokines,chemokines,
and lipid mediators, such as LTs [78, 80, 81].
During a helminth infection such as a nematode infec-
tion, most of the IgE produced binds to mast cells and
basophils through their high-aﬃnity IgE Fc receptor (FcεRI)
[82, 83]. Subsequent exposure of immune cells to parasitic
antigen induces the degranulation of IgE-sensitized mast
cells and the release of both preformed and newly generated
mediators [82]. These mediators, such as LTs, function alone
orinconjunctionwithTh2cytokinestoincreasethecontrac-
tility of smooth muscle cells, the permeability of epithelial
cells and the production of mucus, thereby contributing
to worm expulsion [84]. The experimental gastrointestinal
infection of rats with the nematode Trichinella spiralis de-
monstrated that preimmune rats (previously infected with T.
spiralis) expelled the nematode T. spiralis more rapidly than
nonimmune rats. This eﬀect was associated with the in-
creased production of LTB4 and LTC4 in the gut homogenate
as well as the release of rat mast cell protease II (RMCPII)
in the serum [85, 86]. LTC4 causes smooth muscle contrac-
tion, increases vascular permeability, and stimulates mucus
hypersecretion, and LTB4 recruits and activates inﬂamma-
tory cells such as eosinophils to favor the expulsion of
helminths. Therefore, leukotrienes released from mast cells
may eﬀectively participate in protective immune responses
resulting in the rapid expulsion of T. spiralis and possibly
other helminths. The main eﬀects of LTs, in both innate
and adaptative immune responses, during the helminth in-
fections are illustrated in Figure 3.
Parasitic worm survival in the host for longer periods
depends on the ability of the parasite to evade the host im-
mune system. The ABA-1 protein from Ascaris lumbricoides
(human parasite) and Ascaris suum (pig parasite) is released
by larvae and adult organisms [87, 88]. This protein binds
a range of fatty acids, including LTs [89]. The interaction
betweenABA-1andleukotrienesmightbeassociatedwithan
evasion mechanism; however, further studies are needed to
evaluate the ability of this interaction to inhibit the biologic
eﬀects of LTs in vitro or in vivo.
Brugiamalayiisanematode(roundworm)thatcancause
lymphatic ﬁlariasis in humans. The infective larvae (L3)
of Brugia malayi are transmitted to a vertebrate host by
an insect vector and undergo two molts to develop into
adult worms and complete the life cycle [90]. Interestingly,6 Mediators of Inﬂammation
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Figure 3: Modulation of innate and adaptive immune responses during the helminth infections. Initial exposure of the immune system to
parasitic antigens leads to the activation of a subset of T cells known as Th2 cells, which orchestrate the immune response to these exogenous
antigens by secreting cytokines, including IL-4, IL-5 and IL-13. The accumulation of eosinophils in the blood and in diﬀerent organs and
tissuesaswellasthedegranulationofIgE-sensitizedmastcellsishallmarksofhelminthiasis.EosinophilsandmastcellsaresourcesofLTs.(A)
CysLTs are required for molting of the infectious larvae (e.g., Brugia malayi larvae). (B) CysLTs, alone or in conjunction with Th2 cytokines,
cause contractility of smooth muscle cells, the permeability of epithelial cells, and the production of mucus, thereby contributing to worm
expulsion. (C) LTB4 recruits and activates inﬂammatory cells such as eosinophils to favor the kill of helminths. (D) LTB4 regulates IL-5
production by human T lymphocytes and consequently contributes to parasite elimination. (E) LTB4 induces chemotaxis of CD4+ Tc e l l s .
treatment with inhibitors of lipoxygenases (AA861) or cysLT
biosynthesis (ethacrynic acid or acivicin) or with a cysLT1
antagonist (zaﬁrlukast) inhibited the Brugia malayi L3 larvae
from molting to the L4 stage without altering their survival
or motility. In contrast, U-75302, an antagonist of the LTB4
receptor BTL1, failed to inhibit molting [91]. The γ-glutamyl
transpeptidase, the enzyme that converts LTC4 to LTD4,
has been cloned from Brugia malayi (adult worms) [92].
In another ﬁlaria that causes human infection, Diroﬁlaria
immitis, the glutathione S-transferase, which can function as
an LTC4 synthase, was found in the cytosol of adult worms
[93].Theseresultsdemonstratedthatalipoxygenasepathway
involved in the generation of cysLTs could be required for
molting of the infectious larvae and may possibly have some
role in the adult worm. In vivo models of infection with B.
malayi could be used to better understand the role of cysLTs
in the pathogenesis of ﬁlariasis.
Itiswidelyknownthatsometypesofinfectionsinimmu-
nocompromised individuals are critical in determining the
severity of the disease. The immunosuppression observed
in HIV-seropositive subjects has been associated with Stron-
gyloides spp infections of abnormally high intensity [94].
Interestingly, reduced LT production was observed in HIV-
seropositive patients [14]. In an experimental model that
mimics human strongyloidiasis (mice infected with Strongy-
loidesvenezuelensis),anincreaseintheconcentrationofLTB4
butnotofLTC4 wasobservedinthelungandsmallintestines.
In addition, increased larvae recovery in the lung and/or
increased worm burdens in the intestines were observed
in animals treated with MK886 (a selective inhibitor of
5-lipoxygenase-activating protein (FLAP)) and in 5-LO-
deﬁcient mice than in control animals. Moreover, treatment
of animals with MK886 resulted in decreases of IgG1 and IgE
levels in serum, eosinophil numbers in the blood, peritoneal
cavity and bronchoalveolar ﬂuid volumes and IL-5 concen-
trations in the lung homogenate as well as increased levels
of IL-12, which is involved in the Th1 response. IL-5 is the
major cytokine involved in the accumulation of eosinophilsMediators of Inﬂammation 7
in the blood during allergic inﬂammation and parasitic
infections.Thiscytokineisessentialforeosinophil migration
from the bone marrow to the blood [72, 95] and speciﬁcally
supports the terminal diﬀerentiation and proliferation of
eosinophil precursors as well as the activation of mature
eosinophils [96–99]. LTB4 regulates IL-5 production by
human T lymphocytes [100] and consequently contributes
to parasite elimination. These ﬁndings suggest that LTs, and
speciﬁcally LTB4, might be necessary to control S. stercoralis
infection. Thus, the reduced levels of LTB4 observed in HIV-
seropositive subjects might favor opportunistic hyperinfec-
tion with S. stercoralis; however, further human studies are
needed to evaluate this association.
Toxocara canis is an intestinal parasite of dogs and is
the etiologic agent of toxocariasis, also known as visceral
larva migrans syndrome (VLMS). Infection of both humans
and animals with T. canis is characterized by eosinophilia
in the blood and tissues, increased total serum IgE, and
inﬂammation of the upper respiratory system [72, 95, 101–
104]. During the inﬂammatory response, leukocyte recruit-
ment is directly related to the expression of adhesion mol-
ecules, which allows the transmigration of these blood cells
to the tissues. The integrin adhesion molecules directly con-
tribute to this process [105]. It has been proposed that the
β2 integrin Mac-1 (CD11b/CD18) and the β1 integrin VLA-4
(CD49d/CD29) adhesion molecules are the major molecules
involved in cytokine- and chemokine-induced adhesion and
migration of eosinophils in vitro [106, 107]. LTs can enhance
the expression of Mac-1 on eosinophil cell surfaces [108]. In
mice, T. canis infection causes early upregulation of Mac-1
with late changes in VLA-4 proﬁles on both peritoneal cavity
ﬂuid and bronchoalveolar lavage ﬂuids, whereas MK886
treatmentpromoted the opposite eﬀect.In addition, LT inhi-
bitionhadaclearimpactoneosinophilrecruitmenttotissues
andonbloodeosinophiliathroughoutthecourseofinfection
[12]. In another study, in addition to increased eosinophil
numbers, the researchers showed increased numbers of mast
cells in the peritoneum, lungs, and small intestines of T.
canis-infected rats. Interestingly, these animals increased the
concentration of LTB4 in the serum and this was corre-
lated with mast cell and eosinophil accumulation and/or
recruitment [109]. Thus, LTs might play an important role in
eosinophilic inﬂammation during toxocariasis by inducing
leukocytes recruitment and modulating the expression of
adhesion molecules.
In schistosomiasis, a granulomatous lesion is observed
during chronic infection and causes a range of morbidities
[110]. LTs can control parasite infection by modulating im-
mune responses and through direct cytotoxic eﬀects on the
parasite. LTB4, but not cysLTs (LTC4 and LTD4), enhanced
the ability of neutrophils and eosinophils to kill the schisto-
somula of S. mansoni in a complement-dependent manner
[111]. The cytotoxicity of eosinophils against helminths has
been associated with the expression of cellular receptors
(high aﬃnity IgE receptor, FcεRI) and adhesion molecules
and with degranulation and the release of cationic proteins
[112]. In an in vitro assay, IgE-coated schistosomula induced
eosinophil adherence, resulting in the death of the parasites.
In addition, the release of LTC4 was observed during this
interaction [113]. In agreement with this ﬁnding, schistoso-
mula can produce LTB4 and LTC4 [114]. The function of LTs
in schistosomula is not known; however, their production
might accelerate parasite elimination and/or modulate the
pathogenesis of schistosomiasis.
Schistosome cercariae enter mammalian hosts via a per-
cutaneous route [115]. In addition to the proteolytic en-
zymes produced by cercariae, host-derived skin essential
fatty acids and LTs including LTB4 also play important roles
in the penetration of the skin by the parasite. In an in
vitro assay, increased penetration rates were correlated with
increased LTs levels. In addition, penetration was reduced
upon treatment with a 5-LO inhibitor [116, 117].
Hepaticgranulomatousinﬂammationisobservedduring
schistosomal infection of both humans and mice [110].
Th2 cell-associated cytokines modulate the development of
schistosome egg-induced granulomas. Hepatic stellate cells
(HSCs) are involved in liver remodeling due to collagen
productionanddepositionofextracellularmatrixasaconse-
quence of proliferative and ﬁbrogenic phenotypes induced
by several mediators (cytokines, lipid peroxide, and others)
[118]. mRNA for 5-LO, FLAP and LTC4-synthase and 5-LO
expression was observed in HSCs from schistosomal granu-
lomasofS.mansoni-infectedmice[119].Consequently,these
cells produced cysLTs, but not LTB4, and the production
of cysLTs was increased upon treatment with transforming
growth factor beta (TGF-β, a ﬁbrogenic cytokine). The pro-
liferation induced by TGF-β in HSCs from schistosomal
granulomas of S. mansoni-infected 5-LO-deﬁcient mice or
wild type mice treated with zileuton (5-LO inhibitor) was
reduced [119]. In addition, LTC4 induced TGF-β production
[120], suggesting a synergic eﬀect in schistosomal granu-
lomas. In another study, dipeptidases were isolated from
extracts of hepatic granulomas of mice infected with S. man-
soni; these enzymes increased the hydrolysis of LTD4 to
LTE4 [121], potentially accelerating the metabolism of LTs
and decreasing their eﬀects on liver remodeling. Moreover,
LTB4 and LTC4 are produced by schistosomula and adult
females, while males produced only LTB4 [113]. Together,
these results suggest that cysLT inhibition might inﬂuence
liver remodeling in S. mansoni infection. In this way, CysLT1
antagonists (such as montelukast, zaﬁrlukast, and pranlu-
kast) [4, 122, 123], which are currently used in asthma treat-
ment, could be evaluated for their eﬀects on schistosomal
granuloma remodeling in experimental or human schistoso-
miasis. The main roles of LTs during the helminth infection
are illustrated in Figure 4.
Similar to schistosomiasis, fasciolosis causes liver alter-
ations, which can range from ﬁbrosis to cirrhosis. Fasciolosis
is considered both a human health concern and a veterinary
problem (zoonoses) [124]. During the course of F. hepatica
infection in sheep, a reduction in serum LTB4 was observed
when compared to control animals. Interestingly, LTB4
was produced in both the culture supernatant and the
homogenate of F. hepatica adult parasites recovered from
the bile duct 20 weeks after infection [125]. Moreover,
recruitment of leukocytes consisting mainly of eosinophils,
macrophages, and lymphocytes was observed in the livers8 Mediators of Inﬂammation
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Figure 4: An overview of main eﬀects of LTs in helminth infections. LTs participate of expulsion of T. spiralis in the intestine. The inhibition
of LTs resulted in increases of parasitemia and decreases IgE levels, eosinophil numbers and IL-5 concentrations in mice infected with S.
venezuelensis. LT inhibition also reduced the eosinophil recruitment to tissues and on blood eosinophilia in experimental T. canis infection.
LTB4 enhanced the ability of neutrophils and eosinophils to kill the schistosomula of S. mansoni. LTs play important roles in the penetration
of the skin by the schistosome cercariae. CysLTs are involved in the proliferation and activation of hepatic stellate cells from S. mansoni
granulomas.
of goats infected with F. hepatica [126]. In this way, LTB4
produced by host inﬂammation in synergy with that pro-
ducedbytheparasitecouldcontributetoliveralterationsand
consequent pathology.
4. Conclusion
LTs are associated with the control of helminth and proto-
zoan infections through their ability to modulate inﬂam-
matory processes and/or to promote direct cytotoxicity of
protozoans. In addition, LTs may also be associated with
exacerbatedpathogenesisinprotozoandiseases,suchascere-
bral malaria, and helminthic diseases, such as schistosomal
granulomas.Interestingly,somehelminths(B.malayi)might
use the LTs to complete their development to adult worms.
In addition, other parasites produce LTs (S. mansoni and
F. hepatica) or produce enzymes involved in LT biosyn-
thesis (Diroﬁlaria immitis). Taken together, these ﬁndings
demonstrate that LTs play signiﬁcant roles in protozoan and
helminth infections.
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